Get Premium Data for Cyber Monday: Up to 55% Off InvestingProCLAIM SALE

Dogwood Therapeutics Inc (DWTX)

NASDAQ
Currency in USD
2.370
+0.080(+3.49%)
Closed
After Hours
2.560+0.190(+8.017%)
DWTX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual Post-Market activity
Fair Value
Day's Range
2.2802.511
52 wk Range
1.62023.500
Key Statistics
Edit
Prev. Close
2.29
Open
2.28
Day's Range
2.28-2.511
52 wk Range
1.62-23.5
Volume
13.48K
Average Volume (3m)
106.77K
1-Year Change
-85.21%
Book Value / Share
unlockUnlock
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DWTX Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
13.833
Upside
+483.671%
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility
Show more

Dogwood Therapeutics Inc Company Profile

Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company’s lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It also develops IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Virios Therapeutics, Inc. and changed its name to Dogwood Therapeutics, Inc. in October 2024. The company was founded in 2012 and is headquartered in Alpharetta, Georgia.

Compare DWTX to Peers and Sector

Metrics to compare
DWTX
Peers
Sector
Relationship
P/E Ratio
−0.6x−3.0x−0.6x
PEG Ratio
−0.020.130.00
Price/Book
3.3x2.3x2.6x
Price / LTM Sales
-24.8x3.2x
Upside (Analyst Target)
372.3%176.9%44.6%
Fair Value Upside
Unlock11.6%7.3%Unlock

Analysts' Recommendations

1 Buy
1 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 13.833

(+483.68% Upside)

People Also Watch

0.1785
WBUY
0.00%
2.0400
ELAB
-1.45%
0.490
OMEX
+6.52%
3.7500
GMM
+16.82%

FAQ

What Is the Dogwood Therapeutics (DWTX) Stock Price Today?

The Dogwood Therapeutics stock price today is 2.37

What Stock Exchange Does Dogwood Therapeutics Trade On?

Dogwood Therapeutics is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Dogwood Therapeutics?

The stock symbol for Dogwood Therapeutics is "DWTX."

What Is the Dogwood Therapeutics Market Cap?

As of today, Dogwood Therapeutics market cap is 3.16M.

What is Dogwood Therapeutics Earnings Per Share?

The Dogwood Therapeutics EPS is -6.42.

What Is the Next Dogwood Therapeutics Earnings Date?

Dogwood Therapeutics will release its next earnings report on Mar 13, 2025.

From a Technical Analysis Perspective, Is DWTX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.